Myomo Introduces MyoGames™
Video Games Played via MyoPro for Training, Rehabilitation and Fun CAMBRIDGE, Mass. (November 16, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company offering increased functionality for individuals suffering from neurological disorders and upper-limb paralysis, announced today the availability of MyoGames by Lusio, a video game platform designed […]
Myomo Third Quarter Financial Results Feature Record Revenue of $1.9 Million, up 218% Over the Prior Year
Authorization backlog at a record 162 units, up 35% sequentially Cash utilization of $1.8 million, lowest since scale-up activities began in 2018 Conference call begins at 4:30 p.m. Eastern time today CAMBRIDGE, Mass. (November 10, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality […]
Myomo to Report Third Quarter Financial Results on November 10, 2020
Management to host Financial Results Conference Call at 4:30 p.m. ET CAMBRIDGE, Mass. (November 3, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will report financial results for the […]
Myomo Appoints Dr. Harry Kovelman as Chief Medical Officer
Experienced Physician, Author and Executive to Join Senior Leadership TeamCAMBRIDGE, Mass. (November 2, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Harry Kovelman, MD, is joining the Company as its Chief […]
Myomo to Present at the MicroCap Rodeo Best Ideas Bowl on October 13, 2020
CAMBRIDGE, MA. / ACCESSWIRE (October 7, 2020) – Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, has been invited to present at the MicroCap Rodeo Best Ideas Bowl, which is being held virtually on October 13th – 16th, 2020. Read […]
Myomo Certified as Medicare Provider – Authorization by Centers for Medicare & Medicaid Services Is One More Important Step
CAMBRIDGE, Mass. (September 15, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that the Centers for Medicare & Medicaid Services under the U.S. Department of Health and Human Services has authorized the Company […]
Myomo® to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference
CAMBRIDGE, Mass. (September 10, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that its management is scheduled to present at the H.C. Wainwright 22nd Annual Global Investment Conference to be held virtually on […]
Myomo, Inc. to Present at The LD 500 Virtual Conference
LOS ANGELES, CA / ACCESSWIRE / August 26, 2020 / Myomo, Inc. (NYSE American), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis today announced that it will be presenting at the LD 500 investor conference on Wednesday, September 2, 2020 at 11:00 a.m. EDT. Chairman […]
Myomo® Extends and Strengthens its Global MyoPro™ Patent Portfolio
New Multi-joint Patents in both U.S. and Europe CAMBRIDGE, Mass. (August 26, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced additional intellectual property protection with the issuance of new patents in the […]
Myomo® Receives First Australian Insurance Authorization for MyoPro™
Additional Authorizations Across Australia are Expected to Follow CAMBRIDGE, Mass. (August 20, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that a Myomo-trained Orthotic & Prosthetic (“O&P”) practice in Australia has received […]